Q4 FY26 Earnings: SBI, Titan, Lupin Lead Mega Day

Q4 FY26 Earnings Day: What's Actually Happening May 8, 2025 separates casual market watchers from serious investors. Over a dozen companies are reporting Q4 FY26 results simultaneously, and the early numbers are good enough to matter. [Lupin](/stock/LUPIN) (NSE: LUPIN) has already posted a headline worth paying attention to: net profit up 89% year-on-year to ₹1,460 crore, with revenue growing 31.9%. That's not a rounding error. That's a pharmaceutical company firing on every cylinder. Dabur added to the positive mood with a 15.8% profit rise. The session's heavyweight, though, is still to come. [State Bank of India](/stock/SBIN) (NSE: SBIN) reports today, and the stakes are higher than usual. India's largest public sector bank carries enormous market weight, and its earnings move sentiment across the entire banking sector. Separately, SBI's executive committee has already scheduled a May 12 meeting to consider raising up to $2 billion via foreign currency bonds. That agenda item alone tells you something: SBI's management is confident enough about capital markets to plan a significant overseas fundraise almost immediately after results day. Also reporting: [Titan Company](/stock/TITAN) (NSE: TITAN), Tata Consumer Products (NSE: TATACONSUM), Swiggy (NSE: SWIGGY), Hyundai Motor India (NSE: HYUNDAI), Oberoi Realty (NSE: OBEROIRLTY), Bank of Baroda (NSE: BANKBARODA), and Kalyan Jewellers (NSE: KALYANKJIL). It's a cross-sector stress test happening in real time. Lupin's Numbers and What They Signal for Pharma Let's stay on Lupin a moment longer because 89% profit growth deserves unpacking. The company has benefited from a strong US generics business, steady domestic formulations, and easing input costs. Revenue at roughly ₹5,700 crore reflects genuine volume gains, not price tricks. For investors holding pharma exposure, this is a meaningful data point. It suggests the US FDA approval pipeline is converting into actual revenue, and that currency tailwinds from a rel...